These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10901292)

  • 1. In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine.
    Hostetler KY; Hammond JL; Kini GD; Hostetler SE; Beadle JR; Aldern KA; Chou TC; Richman DD; Mellors JW
    Antivir Chem Chemother; 2000 May; 11(3):213-9. PubMed ID: 10901292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
    Schott H; Hamprecht K; Schott S; Schott TC; Schwendener RA
    Bioorg Med Chem; 2009 Jan; 17(1):303-10. PubMed ID: 19010684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
    Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
    J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells.
    Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Richman DD; Hostetler KY
    Antivir Chem Chemother; 1998 Jan; 9(1):33-40. PubMed ID: 9875375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro.
    Hostetler KY; Kini GD; Beadle JR; Aldern KA; Gardner MF; Border R; Kumar R; Barshak L; Sridhar CN; Wheeler CJ; Richman DD
    Antiviral Res; 1996 Jun; 31(1-2):59-67. PubMed ID: 8793009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance.
    Hammond JL; Koontz DL; Bazmi HZ; Beadle JR; Hostetler SE; Kini GD; Aldern KA; Richman DD; Hostetler KY; Mellors JW
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1621-8. PubMed ID: 11353603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV.
    Kini GD; Beadle JR; Xie H; Aldern KA; Richman DD; Hostetler KY
    Antiviral Res; 1997 Sep; 36(1):43-53. PubMed ID: 9330760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cells.
    Kini GD; Hostetler SE; Beadle JR; Aldern KA
    Antiviral Res; 1997 Nov; 36(2):115-24. PubMed ID: 9443668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Wiley CA; Freeman WR
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal toxicology and therapeutic efficacy of the carboxymethyl ester of the 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA-O-Me), a novel lipid antiviral prodrug for intraocular drug delivery.
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Beadle JR; Wiley CA; Freeman WR
    J Ocul Pharmacol Ther; 1999 Aug; 15(4):363-77. PubMed ID: 10463875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA).
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Severson GM; Freeman WR
    Curr Eye Res; 1999 Mar; 18(3):161-7. PubMed ID: 10342370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Ozerdem U; Bergeron-Lynn G; Mach-Hofacre B; Mueller AJ; Severson GM; Freeman WR
    Retina; 1999; 19(4):325-31. PubMed ID: 10458299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral evaluation of SATE-foscarnet prodrugs and new foscarnet-AZT conjugates.
    Meier C; Aubertin AM; de Monte M; Faraj A; Sommadossi JP; Périgaud C; Imbach JL; Gosselin G
    Antivir Chem Chemother; 1998 Jan; 9(1):41-52. PubMed ID: 9875376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
    Eriksson BF; Schinazi RF
    Antimicrob Agents Chemother; 1989 May; 33(5):663-9. PubMed ID: 2546487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cells.
    Yao K; Hoest C; Rashti F; Schott TC; Jacobson S
    J Clin Virol; 2009 Sep; 46(1):10-4. PubMed ID: 19524486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics.
    Dusserre N; Lessard C; Paquette N; Perron S; Poulin L; Tremblay M; Beauchamp D; Désormeaux A; Bergeron MG
    AIDS; 1995 Aug; 9(8):833-41. PubMed ID: 7576316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.
    Tachedjian G; Mellors J; Bazmi H; Birch C; Mills J
    J Virol; 1996 Oct; 70(10):7171-81. PubMed ID: 8794364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1.
    Koshida R; Cox S; Harmenberg J; Gilljam G; Wahren B
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2083-8. PubMed ID: 2533474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro.
    Hostetler KY; Beadle JR; Kini GD; Gardner MF; Wright KN; Wu TH; Korba BA
    Biochem Pharmacol; 1997 Jun; 53(12):1815-22. PubMed ID: 9256156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.